BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 31331771)

  • 1. Highly conserved influenza T cell epitopes induce broadly protective immunity.
    Eickhoff CS; Terry FE; Peng L; Meza KA; Sakala IG; Van Aartsen D; Moise L; Martin WD; Schriewer J; Buller RM; De Groot AS; Hoft DF
    Vaccine; 2019 Aug; 37(36):5371-5381. PubMed ID: 31331771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Universal influenza DNA vaccine encoding conserved CD4+ T cell epitopes protects against lethal viral challenge in HLA-DR transgenic mice.
    Alexander J; Bilsel P; del Guercio MF; Stewart S; Marinkovic-Petrovic A; Southwood S; Crimi C; Vang L; Walker L; Ishioka G; Chitnis V; Sette A; Assarsson E; Hannaman D; Botten J; Newman MJ
    Vaccine; 2010 Jan; 28(3):664-72. PubMed ID: 19895924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epitope specific T-cell responses against influenza A in a healthy population.
    Savic M; Dembinski JL; Kim Y; Tunheim G; Cox RJ; Oftung F; Peters B; Mjaaland S
    Immunology; 2016 Feb; 147(2):165-77. PubMed ID: 26489873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-protective peptide vaccine against influenza A viruses developed in HLA-A*2402 human immunity model.
    Ichihashi T; Yoshida R; Sugimoto C; Takada A; Kajino K
    PLoS One; 2011; 6(9):e24626. PubMed ID: 21949735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Universal H1N1 influenza vaccine development: identification of consensus class II hemagglutinin and neuraminidase epitopes derived from strains circulating between 1980 and 2011.
    Moise L; Terry F; Ardito M; Tassone R; Latimer H; Boyle C; Martin WD; De Groot AS
    Hum Vaccin Immunother; 2013 Jul; 9(7):1598-607. PubMed ID: 23846304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel peptide-based vaccine candidate with protective efficacy against influenza A in a mouse model.
    Herrera-Rodriguez J; Meijerhof T; Niesters HG; Stjernholm G; Hovden AO; Sørensen B; Ökvist M; Sommerfelt MA; Huckriede A
    Virology; 2018 Feb; 515():21-28. PubMed ID: 29223787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA-A*11:01-restricted CD8+ T cell immunity against influenza A and influenza B viruses in Indigenous and non-Indigenous people.
    Habel JR; Nguyen AT; Rowntree LC; Szeto C; Mifsud NA; Clemens EB; Loh L; Chen W; Rockman S; Nelson J; Davies J; Miller A; Tong SYC; Rossjohn J; Gras S; Purcell AW; Hensen L; Kedzierska K; Illing PT
    PLoS Pathog; 2022 Mar; 18(3):e1010337. PubMed ID: 35255101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The design and proof of concept for a CD8(+) T cell-based vaccine inducing cross-subtype protection against influenza A virus.
    Tan AC; Deliyannis G; Bharadwaj M; Brown LE; Zeng W; Jackson DC
    Immunol Cell Biol; 2013 Jan; 91(1):96-104. PubMed ID: 23146941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Towards the knowledge-based design of universal influenza epitope ensemble vaccines.
    Sheikh QM; Gatherer D; Reche PA; Flower DR
    Bioinformatics; 2016 Nov; 32(21):3233-3239. PubMed ID: 27402904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of broad binding class I HLA supertype epitopes to provide universal coverage of influenza A virus.
    Alexander J; Bilsel P; del Guercio MF; Marinkovic-Petrovic A; Southwood S; Stewart S; Ishioka G; Kotturi MF; Botten J; Sidney J; Newman M; Sette A
    Hum Immunol; 2010 May; 71(5):468-74. PubMed ID: 20156506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MHC class I-presented T cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific T cell response.
    Testa JS; Shetty V; Hafner J; Nickens Z; Kamal S; Sinnathamby G; Philip R
    PLoS One; 2012; 7(11):e48484. PubMed ID: 23144892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A CTL-based liposomal vaccine capable of inducing protection against heterosubtypic influenza viruses in HLA-A*0201 transgenic mice.
    Matsui M; Kohyama S; Suda T; Yokoyama S; Mori M; Kobayashi A; Taneichi M; Uchida T
    Biochem Biophys Res Commun; 2010 Jan; 391(3):1494-9. PubMed ID: 20060099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation at Extra-epitopic Amino Acid Residues Influences Suppression of Influenza Virus Replication by M1
    van de Sandt CE; Pronk MR; van Baalen CA; Fouchier RAM; Rimmelzwaan GF
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29593036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide-pulsed dendritic cells induce the hepatitis C viral epitope-specific responses of naïve human T cells.
    Mishra S; Losikoff PT; Self AA; Terry F; Ardito MT; Tassone R; Martin WD; De Groot AS; Gregory SH
    Vaccine; 2014 May; 32(26):3285-92. PubMed ID: 24721533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with cross-conserved H1N1 influenza CD4+ T-cell epitopes lowers viral burden in HLA DR3 transgenic mice.
    Moise L; Tassone R; Latimer H; Terry F; Levitz L; Haran JP; Ross TM; Boyle CM; Martin WD; De Groot AS
    Hum Vaccin Immunother; 2013 Oct; 9(10):2060-8. PubMed ID: 24045788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In Vivo Validation of Predicted and Conserved T Cell Epitopes in a Swine Influenza Model.
    Gutiérrez AH; Loving C; Moise L; Terry FE; Brockmeier SL; Hughes HR; Martin WD; De Groot AS
    PLoS One; 2016; 11(7):e0159237. PubMed ID: 27411061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conservation and diversity of influenza A H1N1 HLA-restricted T cell epitope candidates for epitope-based vaccines.
    Tan PT; Heiny AT; Miotto O; Salmon J; Marques ET; Lemonnier F; August JT
    PLoS One; 2010 Jan; 5(1):e8754. PubMed ID: 20090904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Highly conserved influenza A sequences as T cell epitopes-based vaccine targets to address the viral variability.
    Tan PT; Khan AM; August JT
    Hum Vaccin; 2011 Apr; 7(4):402-9. PubMed ID: 21471731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein Vaccination Directs the CD4
    Rattan A; Richards KA; Knowlden ZAG; Sant AJ
    J Virol; 2019 Oct; 93(20):. PubMed ID: 31341045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-reactive CD8+ T-cell immunity between the pandemic H1N1-2009 and H1N1-1918 influenza A viruses.
    Gras S; Kedzierski L; Valkenburg SA; Laurie K; Liu YC; Denholm JT; Richards MJ; Rimmelzwaan GF; Kelso A; Doherty PC; Turner SJ; Rossjohn J; Kedzierska K
    Proc Natl Acad Sci U S A; 2010 Jul; 107(28):12599-604. PubMed ID: 20616031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.